Association between the ACAG value and short-term all-cause mortality
Crude model | Model I | Model II | ||||
HR (95% CI) | p value | HR (95% CI) | p value | HR (95% CI) | p value | |
28-day mortality (MIMIC-IV cohort) | ||||||
ACAG (per one unit) | 1.07 (1.06 to 1.09) | <0.001 | 1.08 (1.06 to 1.10) | <0.001 | 1.05 (1.03 to 1.07) | <0.001 |
Higher ACAG level | 1.85 (1.48 to 2.32) | <0.001 | 1.90 (1.52 to 2.39) | <0.001 | 1.42 (1.11 to 1.83) | 0.007 |
ICU mortality (MIMIC-IV cohort) | ||||||
ACAG (per one unit) | 1.06 (1.04 to 1.09) | <0.001 | 1.07 (1.05 to 1.09) | <0.001 | 1.04 (1.01 to 1.06) | 0.005 |
Higher ACAG level | 1.74 (1.33 to 2.28) | <0.001 | 1.87 (1.43 to 1.91) | <0.001 | 1.43 (1.05 to 1.93) | 0.022 |
ICU mortality (eICU-CRD cohort) | ||||||
ACAG (per one unit) | 1.06 (1.04 to 1.08) | <0.001 | 1.07 (1.05 to 1.09) | <0.001 | 1.06 (1.03 to 1.09) | <0.001 |
Higher ACAG level | 1.61 (1.22 to 2.11) | <0.001 | 1.65 (1.25 to 2.17) | <0.001 | 1.38 (1.02 to 1.86) | 0.036 |
In-hospital mortality (MIMIC-IV cohort) | ||||||
ACAG (per one unit) | 1.06 (1.04 to 1.08) | <0.001 | 1.06 (1.04 to 1.08) | <0.001 | 1.04 (1.02 to 1.07) | <0.001 |
Higher ACAG level | 1.51 (1.20 to 1.91) | <0.001 | 1.58 (1.25 to 2.01) | <0.001 | 1.31 (1.01 to 1.71) | 0.041 |
In-hospital mortality (eICU-CRD cohort) | ||||||
ACAG (per one unit) | 1.06 (1.04 to 1.08) | <0.001 | 1.07 (1.05 to 1.09) | <0.001 | 1.05 (1.02 to 1.07) | <0.001 |
Higher ACAG level | 1.81 (1.41 to 2.33) | <0.001 | 1.86 (1.44 to 2.39) | <0.001 | 1.47 (1.12 to 1.94) | 0.006 |
Model I was adjusted for age, sex, race and weight/body mass index.
Model II was adjusted for age, sex, race, weight/body mass index, acute myocardial infarction, cardiomyopathy, atrial fibrillation, valvular heart disease, diabetes, chronic obstructive pulmonary disease, acute kidney injury, SOFA score, mean blood pressure, oxygen saturation, potassium, chloride, creatine and total bilirubin.
ACAG, albumin-corrected anion gap; HR, hazard ratio; CI, confidence interval.